Member Info for Jet7

Hopefully with FDA approval being expected in 5/6 months time, FUM with knowledge gained from there work closer to home, will in the meantime put everything in place so that launch in the US can happen shortly after receiving confirmation.

We certainly do not want or expect to be waiting for very long for the biggest market in the world to come online. Today I would say that FUM is in the strongest position it ever has been, with all the ground work having been put in place over this last 18 months, there can be no further excuses. Some shareholders have been waiting for this moment for far too many years, but we are arriving at the station and I hope FUM management and staff are going to deliver and make this company and product into a successful and known brand worldwide.

81Lucky, your last line ,” hostile takeover over”, whether or not hostile , I believe you are right! This is looking primed to be taken over in my eyes. My personal thoughts are sales are going to be massive, why would anyone not give it a go with everything we know about Eroxon against the other alternatives. Also I don’t care what the market thinks of the BoD’s. They have a plan and are quietly implementing it, making sure they can deliver their end and personally I think the company will eventually be taken over. If FUM get it right their end and deliver, it should be at an exceptionally cracking price.

Possibly lots, partnerships with further new territories around the world, perhaps notice of launch dates or they may surprise us and even launch this year and very soon how and where we stand financially, to me this is important going forward.

I have to remind myself that FUM are a R&D company, by my reckoning they have decided to go it alone and keep hold of the product after having their fingers burnt so many times previously.
Now manufacturing the product along with distribution is not sorted quickly. But in doing this they still own 100% or the product.

Get all this right along with FDA on board , then calculate the value of the company!

Italian, JB states on Proactive interview it will be launched by April 23, I think the launch of Eroxon will coincide with hopefully approval by the FDA. Imagine the publicity worldwide at that point. Passed two separate trials, over the counter, day time tv and magazines will love it.
Nothing better than a gel with no drugs to assist millions having intercourse. Fabulous!

Not sure where you got launch 22 from, however I do agree.

They are not prepared to launch until everything is absolutely right, that I believe indicated everything on the partners front too. I dare say there must be many issues that we on this board have not considered, neither were they letting on as to which the first area would be to launch the product even if they are aware.

They seem to be very happy with their choice of partnerships and obviously who they are now working along side. I dare say they (partners) are now having a say as to when launch will take place, all that I can say is, as JB said in his interactive interview that launch would happen by April 23 was reiterated to me. Personally I suspect it will be well before.

I spoke with three main directors at the AGM, I sensed an air of confidence from all three. They are hopeful of delivering further partnership deals around the world , positive trial results in America in September to reciprocate both the EU and Coopers in house trial.

They still remain open minded on any potential agreement in America, keeping all options open.

In my opinion this stock is still way under the radar of investors, I reckon all positive with much to look forward too, both now and heading into 23. AIMO

Lombard sitting here with a plus £23m investment, three weeks to AGM, three months to FDA results. Surely positive information coming from the AGM, must be time for the share price to finally , slowly start advancing on forth coming news. Fingers crossed guys and girls!

AGM should be due in months time, all starting to heat up shortly I would suggest, really looking forward to the launch of Eroxon. See what the strategy is along with their worldwide partners, should be exciting times for all that have been here years, have to say I believe both the company and long term share holders deserve success and reward for the longevity and verbal attacks that have been made over the years.

Great appointments to strengthen the board have been put in place in recent times. Launching in September along with hopeful approval from the FDA sounds like a great recipe to me, those combined alone should bring great publicity. If I’m correct it would in my eyes be a great strategy for launch.

Not long now, let’s hope we are all raising a glass in the not to distant future, Futura and Eroxon!

I very much like the tie up with Coopers, American results due in just over three months time. FUM have full control of Med 3000, but having gone down the path of using various partners they now have to deliver in both supply of the product and support. We all know how things have and are changing in recent times with delivery, fulfilling these tasks will be no mean feat in days like today,we know FUM is a small company, they will likely and hopefully be inundated with demands from across the world. It just does not happen that easily and will be new to FUM. Probably new staff etc etc. It all just doesn’t happen. Last thing we as long term shareholders need now is for it all to go wrong due to rushing, I am sure they must be extremely busy in getting everything ready and at the same time liaising with the various partners.

I would suggest that all that needs to be sorted prior to launch is a massive undertaking, so although frustrated we need a little more patience, they simply cannot afford to **** this up.

https://www.proactiveinvestors.co.uk/companies/news/982961/futura-medical-upgraded-after-cooper-health-deal-982961.html

Next date to look forward to, mid September and surely a given of a pass by the FDA with this news. That 27p looks pretty cheap today!

TRIG used to be around parity with UKW, decisions made by management have meant we have now been left with approximately a 26p deficit in share price valuation. All down to management decisions I would suggest. We seem to be treading water presently in times where other renewables are heading north. I would have hoped for better foresight and choices than appear to have been made, wonder if there will be a change in their strategy.

All very simple, Med passes the FDA trial to back up the phase 3 results and this baby is going to take off! Obviously other contributors are at play as in distributors, but FUM have taken their time allowing everything to be put in place. No stone left unturned they’ve been burnt too many time previously, they have learnt and I believe mistakes of the past are now standing the company in good order. AIMO

We’ve all been frustrated this last year, but now with hindsight I believe the board knew exactly, that it was going to take this long to progress. They have multiple distributors, so no excuse as we’ve seen in the past with a product not being sold by our one partner for whatever reason, If we get one bad egg (distributor) or even two, there will be many others that are selling Eroxon, they I believe have taken their time, hopefully got it right, who’s going to complain if by this time next year we have launched in various territories, along with FDA approval! Highly likely if that’s the case the price could be triple of where it is today.

Also with where the world economy is, to have our money invested in healthcare cannot be a bad thing. JB said on Proactive recently, “another cog in the wheel”, be patient guys, not long now, plus it should be all positive news going forward driving the share price north.

The article posted here today by TheT, mail online, adds massively to the value of Eroxon, so not only the forthcoming news on further distribution deals, results of the FDA study, now how dangerous other treatments for ED can potentially be.

All this is music to the ears of FUM and it’s share holders! This must add seriously even more value to the product.

So glad I hung on in here despite all the garbage written on chat rooms.

Now over to you board of directors, with this added news , I will say I think with the various distributors around the world and no longer being dependent on one partner , it’s time to bring home the bacon!!

Love the way management are issuing the RNS’s, keeping us shareholders right up to date in these turbulent times. It’s very clear they have their finger on the pulse, pre-empting the scenarios the company may face.

I’m massively down here, but averaged down as much as is possible. Really hope they don’t pay the dividend , keep to ensure the company has plenty of liquidity. For me personally, this is all about sustaining a viable company no matter how long it takes to get through all this and bring the share price eventually back to where it belongs.

Or even sajy.

saucy, Funny you should suggest that, Lombard sold massively into the phase 3 results at a huge profit and now they are buying into this coming period with various happenings.

Exactly that Italian, just as things are getting interesting they in my eyes they have literally stolen a further 3% of the company at what is no money, I feel I’ve managed to do the same however, so can’t really complain.

It does now leave them in an extremely strong position, I suppose they are only looking after their own interests which they cannot be blamed for. However shareholders need to be aware of this in my view, I’m not au fait with takeover rules but having seen Lombard as saviours, they could easily become a Predator. I suppose the share price would rise considerably if this were the case though.

What also riles me, is I feel it is likely that many small pi’s have possibly sold on the back of postings on these boards, it is shocking if I’m right. You have to ask yourself how have Lombard managed to pick up the quantity in such a short time and the price has still gone down. Almost certainly small holders have got out in that time.

Perhaps investors with more knowledge than me can enlighten on takeover rules of an aim company.